Zobrazeno 1 - 10
of 472
pro vyhledávání: '"Inabnet, William"'
Autor:
Orozco, Gabriel, Cannon, Robert M., Mei, Xiaonan, Inabnet, William B., III, Evers, B. Mark, Gedaly, Roberto, Goldberg, David S., Shah, Malay B.
Publikováno v:
In Surgery December 2024 176(6):1754-1760
Autor:
Mathur, Aarti, Alkhalili, Eyas, Beck, Tim, Cisco, Robin, Goldfarb, Melanie, Phay, John E., Miller, Barbra S., Solórzano, Carmen C., Sippel, Rebecca S., Rosen, Jennifer E., Schneider, David F., Inabnet, William B., 3rd
Publikováno v:
In Surgery December 2024 176(6):1776-1779
Publikováno v:
In Surgical Oncology Clinics of North America April 2023 32(2):373-381
Autor:
Hsiao, Vivian, Kazaure, Hadiza S., Drake, Frederick T., Inabnet, William B., III, Rosen, Jennifer E., Davenport, Daniel L., Schneider, David F.
Publikováno v:
In Surgery January 2023 173(1):215-225
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Acheampong, Derrick, Guerrier, Shanice, Lavarias, Valentina, Pechman, David, Mills, Christopher, Inabnet, William, Leitman, I. Michael
Publikováno v:
In Annals of Medicine and Surgery September 2018 33:40-43
Autor:
Acheampong, Derrick, Guerrier, Shanice, Lavarias, Valentina, Pechman, David, Mills, Christopher, Inabnet, William, Boateng, Percy, Leitman, I. Michael
Publikováno v:
In Annals of Medicine and Surgery September 2018 33:16-23
Autor:
Taye, Aida, Gurciullo, Dillon, Miles, Brett A., Gupta, Ashita, Owen, Randall P., Inabnet, William B., III, Beyda, Jessica N., Marti, Jennifer L. *
Publikováno v:
In Surgery January 2018 163(1):97-103
Autor:
Ho, Alan L., Dedecjus, Marek, Wirth, Lori J., Tuttle, R. Michael, Inabnet, William B., Tennvall, Jan, Vaisman, Fernanda, Bastholt, Lars, Gianoukakis, Andrew G., Rodien, Patrice, Paschke, Ralf, Elisei, Rossella, Viola, David, So, Karen, Carroll, Danielle, Hovey, Tina, Thakre, Bhavana, Fagin, James A.
Publikováno v:
J Clin Oncol
PURPOSE Selumetinib can increase radioactive iodine (RAI) avidity in RAI-refractory tumors. We investigated whether selumetinib plus adjuvant RAI improves complete remission (CR) rates in patients with differentiated thyroid cancer (DTC) at high risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88bbfbab82a2d9ea967c621a073fd7d8
https://doi.org/10.1200/jco.21.00714
https://doi.org/10.1200/jco.21.00714
Autor:
King, Wendy C., Chen, Jia-Yuh, Courcoulas, Anita P., Mitchell, James E., Wolfe, Bruce M., Patterson, Emma J., Inabnet, William B., Dakin, Gregory F., Flum, David R., Cook, Brian, Belle, Steven H.
Publikováno v:
In Preventive Medicine March 2016 84:12-18